conjunctivitis
Information
- Disease name
- conjunctivitis
- Disease ID
- DOID:6195
- Description
- "A conjunctival disease characterized by an inflammation of the conjunctiva, the outermost layer of the eye and the inner surface of the eyelids." [url:http\://en.wikipedia.org/wiki/Conjunctivitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00001734 | Completed | Screening for NEI Clinical Studies | March 23, 1998 | October 3, 2008 | |
| NCT00008541 | Completed | Evaluation and Treatment of Patients With Corneal and External Diseases | January 2, 2001 | March 6, 2009 | |
| NCT00522600 | Completed | Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations | February 2007 | July 2007 | |
| NCT00550550 | Completed | Phase 3 | Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) | November 2007 | September 2009 |
| NCT00562159 | Completed | Phase 3 | Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) | November 2007 | September 2009 |
| NCT00567762 | Completed | Phase 3 | Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis | February 2004 | September 2004 |
| NCT00567918 | Completed | Phase 3 | Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis | May 2004 | January 2008 |
| NCT00581542 | Completed | Phase 4 | Moxifloxacin vs. Polytrim for Conjunctivitis | March 2007 | March 2012 |
| NCT00623701 | Completed | Phase 3 | Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation | March 2008 | October 2012 |
| NCT00705159 | Completed | Phase 4 | Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis | June 2008 | May 2010 |
| NCT00732446 | Completed | Phase 3 | Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis | August 2008 | February 2009 |
| NCT00770315 | Completed | Phase 2/Phase 3 | Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) | September 2009 | May 2011 |
| NCT00783198 | Completed | Phase 2/Phase 3 | Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) | September 2009 | May 2011 |
| NCT00857779 | Completed | Phase 2 | Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients | February 2009 | October 2009 |
| NCT00921895 | Completed | N/A | A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis | June 2009 | June 2011 |
| NCT00978029 | Completed | Phase 2 | Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) | November 2009 | February 2010 |
| NCT01028027 | Completed | Phase 3 | Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis | October 2009 | March 2010 |
| NCT01385371 | Completed | Phase 3 | A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) | June 2011 | August 2012 |
| NCT04709575 | Completed | Phase 3 | Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis | January 14, 2021 | August 24, 2021 |
| NCT04837534 | Completed | N/A | Improving the Follow up Rate for Pediatric Patients | February 15, 2021 | December 30, 2021 |
| NCT04984941 | Completed | Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients | March 1, 2013 | October 1, 2014 | |
| NCT05430919 | Completed | Phase 2 | Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants | August 15, 2022 | July 31, 2023 |
| NCT06092515 | Completed | N/A | Efficacy of Zinc Fortified Fermented Wheat Flour | January 1, 2023 | May 31, 2024 |
| NCT02472223 | Completed | N/A | Reducing Adenoviral Patient Infected Days | March 23, 2015 | June 1, 2018 |
| NCT02503956 | Completed | N/A | Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients | August 2015 | July 22, 2016 |
| NCT03519516 | Completed | Phase 1 | Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects | January 25, 2018 | June 10, 2018 |
| NCT03753893 | Completed | Ocular Manifestations in Rheumatic Diseases | May 1, 2013 | November 1, 2021 | |
| NCT04287608 | Completed | Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis | March 10, 2021 | March 29, 2023 | |
| NCT04374656 | Completed | Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic | May 18, 2020 | May 29, 2024 | |
| NCT06229379 | Recruiting | N/A | The Effects of a Large Language Model on Clinical Questioning Skills | September 1, 2023 | June 2024 |
| NCT01600365 | Unknown status | Phase 3 | Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus | May 2012 | June 2012 |
| NCT03631108 | Unknown status | Feasibility Study and Preliminary Application Study on Iris OCTA | October 2018 | June 2019 | |
| NCT04346160 | Unknown status | A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease | April 14, 2020 | April 30, 2020 | |
| NCT02795273 | Withdrawn | Phase 2/Phase 3 | Efficacy and Safety of Grass-SPIRE Registration Study | May 2016 |
- Disase is a (Disease Ontology)
- DOID:4251
- Cross Reference ID (Disease Ontology)
- ICD10CM:H10
- Cross Reference ID (Disease Ontology)
- ICD9CM:372.30
- Cross Reference ID (Disease Ontology)
- MESH:D003231
- Cross Reference ID (Disease Ontology)
- NCI:C34504
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:193857008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0009763
- Disase Synonym (Disease Ontology)
- Madras eye
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000509
- ICD10 preferred id (Insert disease from ICD10)
- D0006030
- ICD10 class code (Insert disease from ICD10)
- H10
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003231